3.06
price up icon9.68%   0.27
after-market Handel nachbörslich: 3.06
loading

Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.14%
10.87
10.34 11.20 10.35 11.11
Operating Income/Loss
5.14%
-10.87
-10.34 -11.20 -10.35 -11.11
Income/Loss From Continuing Operations Before Tax
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Income/Loss From Continuing Operations After Tax
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Net Income/Loss
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,560%
29.99
1.8061 29.97 24.01 14.29
Diluted Average Shares
1,560%
29.99
1.8061 29.97 24.01 14.29
Basic Earnings Per Share
17.24%
-0.34
-0.29 -0.35 -0.40 -0.75
Diluted Earnings Per Share
17.24%
-0.34
-0.29 -0.35 -0.40 -0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):